Best practice guidelines on publishing ethics: a publisher's perspective, 2nd edition

Wiley has updated its publishing ethics guidelines, first published in 2006. The new guidelines provide guidance, resources and practical advice on ethical concerns that arise in academic publishing for editors, authors and researchers, among other audiences. New guidance is also included on whistle blowers, animal research, clinical research and clinical trial registration, addressing cultural differences, human rights and confidentiality. The guidelines are uniquely interdisciplinary, and were reviewed by 24 editors and experts chosen from the wide range of communities that Wiley serves. They are also published in Advanced Materials, Headache, Annals of the New York Academy of Sciences, Social Science Quarterly, and on the website http://exchanges.wiley.com/ethicsguidelines.     

Ethical publishing in intensive care medicine: A narrative review

Ethical standards in the context of scientific publications are increasingly gaining attention. A narrative review of the literature concerning publication ethics was conducted as found in PubMed, Google Scholar, relevant news articles, position papers, websites and other sources. The Committee on Publication Ethics has produced guidelines and schedules for the handling of problem situations that have been adopted by professional journals and publishers worldwide as guidelines to authors. The defined requirements go beyond the disclosure of conflicts of interest or the prior registration of clinical trials. Recommendations to authors, editors and publishers of journals and research institutions were formulated with regard to issues of authorship, double publications, plagiarism, and conflicts of interest, with special attention being paid to unethical research behavior and data falsification. This narrative review focusses on ethical publishing in intensive care medicine. As scientific misconduct with data falsification damage patients and society, especially if fraudulent studies are considered important or favor certain therapies and downplay their side effects, it is important to ensure that only studies are published that have been carried out with highest integrity according to predefined criteria. For that also the peer review process has to be conducted in accordance with the highest possible scientific standards and making use of available modern information technology. The review provides the current state of recommendations that are considered to be most relevant particularly in the field of intensive care medicine.     

Best Practice Guidelines on Publication Ethics: a publisher's perspective

These Best Practice Guidelines on Publication Ethics describe Blackwell Publishing's position on the major ethical principles of academic publishing and review factors that may foster ethical behavior or create problems. The aims are to encourage discussion, to initiate changes where they are needed, and to provide practical guidance, in the form of Best Practice statements, to inform these changes. Blackwell Publishing recommends that editors adapt and adopt the suggestions outlined to best fit the needs of their own particular publishing environment.     

Ethical issues faced by nursing editors

This study reports on ethical issues faced by editors of nursing journals, a topic which has not appeared in the nursing literature. A survey of nursing editors (n = 88)was conducted via e-mail; this article is the content analysis of survey questions about ethics. Eight categories of ethical issues emerged: problems with society/association/publisher; decisions about inflammatory submissions; informed consent or IRB issues; conflicts of interest; advertising pressures; duplicate publications and/or plagiarism; difficult interactions with authors; and authorship. Some issues were similar to those published about medical editors; however, others were unique. This study can assist authors to better understand some of the ethical issues in publishing, can help editors to view their issues in the context of what others experience, and can assist societies and publishers to work toward avoiding these ethical issues in the future. Professional discussions about ethics in nursing publications should be the subject of ongoing research and scientific inquiry.     

基于数据挖掘的妊娠期运动研究热点及趋势分析

目的：了解我国近十年妊娠期运动的研究热点及趋势,为国内妊娠期运动的相关研究提供方向和思路。方法：以“妊娠期”并含“运动”为主题词检索中国知网2010年至2019年发表的文献,采用Citespace对相关文献的作者、研究机构和关键词进行分析。结果：共纳入文献681篇,发文量≥2篇的作者有46名,研究结构有26家,形成6个关键词聚类标签：#0孕妇、#1运动指导、#2心理护理、#3动态血糖监测、#4妊娠并发症、#5预见性运动护理。结论：目前尚未形成核心的作者和作者群,缺少跨机构的科研合作。目前已有妊娠期糖尿病患者运动干预的方法、时间及频率的指南,但目前尚无权威的专家共识或是指南明确孕期妇女是否需要进行运动以及如何选择正确的运动方式,在未来的研究中建议以聚类结果为依据,进一步开展高质量的多中心的随机对照研究,为国内制定及完善孕期规范化、系统化运动保健指南提供循证依据。     

2003-2012年护理学高被引论文学术特征分析及启示

目的：为护理学期刊编辑选题、组稿,提升期刊质量和学术影响力提供参考。方法：运用文献计量学方法,从期刊、发表栏目、主题、研究方法、基金资助5方面进行描述性统计分析。结果：护理学高被引论文期刊、发表栏目、研究方法呈集中性分布,主题呈集中性和动态性分布,基金资助以院校、省级为主,省级基金资助比例高于国家级基金。结论：护理学期刊编辑应围绕研究热点展开选题,加强产生高被引论文栏目建设与组稿,积极挖掘优质稿源,提高国家级基金资助论文的刊出比例。     

Medicines for hypertension: changes to the UK NICE guidelines

New NICE guidance on the use of medicines for hypertension, published in June 2006, will prompt a major review of treatment for those already receiving medication and also sets out a new treatment pathway for the newly diagnosed. The major change in the guidelines is in the status of beta blockers, which are no longer to be used as a routine treatment for hypertension. The guidelines provide a consensus on treatment, and nurses and their patients now have a clear and straightforward algorithm to follow. It is envisaged that these changes to the way medicines are prescribed for hypertension will have a significant impact on the number of people reaching their target blood pressure, and therefore the number of cardiovascular events occurring each year.     

Year in review 2010: Critical Care - multiple organ dysfunction and sepsis

This review summarizes new insights in the pathophysiologic implications of inflammation and microvascular alterations in organ dysfunction, as well as genetic factor contribution, from clinical and experimental studies that were published in 2010 in Critical Care in the fields of multiple organ dysfunction and sepsis. New diagnostic and prognostic markers of organ dysfunction are presented. Evaluations of novel therapeutic strategies, including implementation of international guidelines, modulation of inflammation and coagulation, and prevention of ventilator-induced lung injury and acute kidney injury, are reported. The results of these experimental studies and clinical trials are discussed in the context of the current relevant scientific and clinical background.     

2019年期刊公开发表的中国临床实践指南文献调查与评价——传播与实施情况

  目的  分析2019年期刊公开发表的中国临床实践指南传播与实施情况,为推动我国临床实践指南的转化与落地提供建议。  方法  针对2019年期刊公开发表的中国临床实践指南传播与实施相关内容报告情况,以及指南多期刊、多版本、多语种发表情况进行分析。同时,分析2019年中国临床实践指南解读类文献的发表情况,进一步了解我国指南的传播与实施现状。  结果  2019年期刊公开发表的中国临床实践指南共226篇,仅5.8%(13/226)报告了传播与实施相关内容。共报告了12种传播与实施策略,其中通过学术会议及多媒体平台促进指南传播与实施被报告的次数最多,在8篇指南中均进行了报告。在传播与实施策略的应用方面,12.4%(28/226)的指南在多本期刊上公开发表,9.3%(21/226)的指南发表了不同版本,8.4%(19/226)的指南分别以中、英文语种进行发表。对2019年中国指南的解读类文献进行检索,共纳入48篇文献,分别对30篇(13.3%,30/226)指南进行了解读。指南与解读类文献发表的中位时间间隔为5.5个月。  结论  2019年期刊公开发表的中国临床实践指南中传播与实施的报告率及相关策略的应用率均较低,建议指南制订者在指南制订过程中应制订有针对性、形式多样的传播与实施策略,并在撰写时遵循相应的报告规范。     

Better laboratory evaluations of instruments and kits are required

There are many published protocols for evaluating instruments and reagent-kit sets, and a plethora of papers describe the results of evaluations performed. It might be assumed, therefore, that this facet of clinical chemistry has no problems, but examination of evaluations of instruments published in the first half of 1984 shows flaws in some aspects of experimental design and execution, statistical analysis, and interpretation of data. We believe that clinical chemists, manufacturers and suppliers, and journal editors and referees can all contribute to improvement of this situation, and we suggest some guidelines for each of these groups.     

So you want to do research? 6: Reporting research

This last article of the series reviews some of the key issues that need to be considered when preparing your research findings for dissemination. Dissemination is an integral part of the research process and this article outlines some of the initial steps that need to be taken, including the establishment of agreements between authors. The importance of writing for a specific audience and how this determines the content of the report is then discussed. An overview together with guidelines on how to report qualitative and quantitative research is presented. General guidance on the choice of title, writing an abstract, listing references and acknowledgements are discussed. The article concludes with an outline of some of the key criteria editors use when reviewing a paper for publication.     

New pharmacotherapy options for chemotherapy-induced alimentary mucositis

Introduction: Chemotherapy-induced alimentary mucositis is an extremely common condition that is caused by a breakdown of the mucosal barrier. It occurs in between 40 – 100% of cancer patients depending on the treatment regimen. Symptoms typically include pain from oral ulceration, vomiting and diarrhoea. Alimentary mucositis often necessitates chemotherapy reductions or treatment breaks, overall potentially compromising survival outcomes. Consequently, alimentary mucositis creates a burden not only on patients' quality of life but also on healthcare costs. Despite this, currently, there is no clinically effective localised/pharmacological therapy intervention strategy to prevent alimentary mucositis.

Areas covered: Over recent years, a number of novel pharmacotherapy agents have been trialed in various preclinical and clinical settings. This critical review will therefore provide an overview of emerging pharmacotherapies for the treatment of alimentary mucositis following chemotherapy with particular emphasis on studies published in the last 2 years. A Pubmed literature search was conducted to identify eligible articles published before 30 November 2013 and each article was reviewed by all authors. All articles were written in English.

Expert opinion: Currently, there is no clinically effective localised therapeutic intervention strategy to prevent the condition. New emerging areas of research have recently been proposed to play key roles in the development of alimentary mucositis and these areas may provide researchers and clinicians with new research directions. Hopefully this will continue, and evidence-based informed guidelines can be produced to improve clinical practice management of this condition.